modest (0.3-1)

Model-Based Dose-Escalation Trials.

User-friendly Shiny apps for designing and evaluating phase I cancer clinical trials, with the aim to estimate the maximum tolerated dose (MTD) of a novel drug, using a Bayesian decision procedure based on logistic regression.

Maintainer: Philip Pallmann
Author(s): Philip Pallmann [aut, cre], Fang Wan [aut]

License: GPL-2

Uses: knitr, rhandsontable, shiny, shinyBS

Released over 2 years ago.